Sequential segmental classification of feline congenital heart disease

Brian A Scansen1, Matthias Schneider2, John D Bonagura1

  • 1Department of Clinical Sciences, The Ohio State University College of Veterinary Medicine, 601 Vernon L Tharp St., Columbus, OH 43210, USA.

Insights

Feline congenital heart disease, though rare, requires understanding diverse lesions and classifications. This review offers a framework for diagnosis and treatment using a sequential segmental approach.

Area of Science:

  • Veterinary Cardiology
  • Comparative Pathology

Background:

  • Feline congenital heart disease is less common than acquired forms like cardiomyopathy.
  • Understanding congenital cardiovascular disease requires familiarity with varied lesions, nomenclature, and classifications.

Purpose of the Study:

  • To provide an overview of feline congenital heart disease.
  • To present specific congenital defects using a sequential segmental classification.
  • To offer a framework for approaching congenital heart disease in cats and other species.

Main Methods:

  • Review of existing literature on feline congenital heart disease.
  • Organization of defects by a sequential segmental classification.
  • Adaptation of methodologies used in human congenital heart disease.

Main Results:

  • Overview of proposed etiologies, prevalence, examination, and therapy principles.
  • Detailed presentation of specific congenital defects with morphologic lesions.
  • Highlights on diagnosis, treatment, and prognosis for feline congenital heart disease.

Conclusions:

  • The sequential segmental approach provides a structured method for understanding feline congenital heart disease.
  • This approach can be adapted for diagnosing and managing congenital heart disease in other animal species.
  • A comprehensive understanding aids in veterinary clinical practice.

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
576
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
796
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
687
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.4K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
989